Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Bethesda Handbook of Clinical Oncology
Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. The Bethesda Handbook of Clinical Oncology is a comprehensive review of the management of numerous cancer types, emphasizing practical information that can be applied in everyday, fast-moving patient care situations. With contributions from experts and scholars at the National Cancer Institute, National Institutes of Health, Cleveland Clinic, and other renowned institutions, this latest edition has been thoroughly revised with new content and continues to provide practical guidance on how to evaluate, diagnose, and treat cancer patients.
Leukemia
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of leukemia treatment. Leukemia treatment has undergone major change over the course of the past few years and Leukemia addresses current best practices in the light of the most recent evidence. All of the chapters are written by international experts in the field, address the common clinical scenarios in leukemia and are multidisciplinary in scope covering surgical, medical, immunotherapy, and stem cell transplantation. Chapters examining novel and targeted therapies, infections, and reduced intensity allogeneic transplantation round out the coverage. Emerging Cancer Therapeuti...
ERS.
None
Renal Cancer
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of renal cancer treatment. Renal cancer treatment has undergone major changes over the course of the past few years and Renal Cancer addresses current best practices in the light of the most recent evidence. All of the chapters are written by international experts in the field, address the common clinical scenarios in renal cancer and are multidisciplinary in scope covering surgical, medical, and radiation therapy. Chapters examining emerging and novel therapeutic targets, the management of both CNS, and skeletal metastases in renal cancer round out the coverage. Emerging Cancer...
Immunotherapy
The field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of Immunotherapy provides the most current overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. While immunotherapy has revolutionized the treatment landscape of several solid malignancies, several challenges still exist. Only a subset of patients derive clinical benefits; some do not respond at all, and others respond initially, only for their disease to progress later. Because these drugs can activate a broad range of immune cells, patients suffer from a unique set of side effects known as immune-related adverse events....
Immunomodulating Drugs for the Treatment of Cancer
Immunomodulating Drugs for the Treatment of Cancer provides a comprehensive resource for clinicians and researchers regarding immunomodulatory (IMiDs) drugs and their rapidly emerging role in cancer medicine. This new class of anticancer agents has made a tremendous impact on the treatment of patients with various malignant diseases, including blood cancers and several cancers of the solid organs. Their popularity in prescribing is based on several important characteristics including: (1) oral bioavailability, (2) non-chemotherapeutic, (3) extremely well-tolerated in all age groups, (4) ability to activate patient's own immune response against cancer, (5) ease of combination with other agents such as chemotherapy resulting in higher responses as well as (6) variability of anticancer activity.
Progress in Oncology 2004
The fourth volume in this outstanding series of annual updates in oncology, Progress in Oncology 2004 addresses fifteen of the most important "hot topics" in the field. Under the careful direction of Drs. DeVita, Hellman, and Rosenberg, each volume in this exciting series presents concise summaries of the state of the art in cancer basic science and clinical application, written by 15 of the top researchers and clinicians in the world.As with all the volumes in the series, PIO 2004 covers critical issues in clinical cancer care and research in a scholarly though readable style. Chapters on advances in treatment and diagnosis, including DNA microarrays, growth factor receptors, new applications of thalidomide, and allografting in NHL review the state of the art in these emerging fields. Top experts provide timely overviews of focused ultrasound therapy, hormone therapy for prostate cancer, and CHOP and rituxin for DLCL. In a special surgery section, world-class authorities discuss approaches to rectal cancer. These and other rigorously referenced chapters make PIO 2004 an indispensable new oncology resource.
